In addition to mucinous metaplasia and eosinophilic cell change, MUC5AC was also positive in 100% of surface syncytial change (although only two cases) and 52% of ciliated (tubal) change.

Eosinophilic asthma is an uncommon type of asthma that’s often severe. It’s named after immune cells called eosinophils, which can go into overdrive and make it harder for you to breathe.

The FDA granted approval to mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...

Eosinophilic granuloma is a rare, noncancerous tumor that shows up in the bone. The condition involves the overproduction of specific immune cells in the body. The exact cause of eosinophilic ...

Eosinophilic granuloma (EG) is a type of lesion that usually appears on bones. These lesions are caused by an overgrowth of Langerhans cells, which are naturally occurring white blood cells that ...

In patients with eosinophilic esophagitis, etrasimod led to sustained histologic and endoscopic improvement over a year, with ...

Respiratory syncytial virus (RSV), originally recovered ... the inflammatory response is normally mediated by type 2 helper T cells. This response later switches to a pattern mediated primarily ...

The patient had a clinically established eosinophilic esophagitis milk allergy. Conventional T cells that expressed eoeTCR-4 proliferated when researchers stimulated them with recombinant beta-casein.

chronic) and which type of blood cells are affected (myeloid vs. lymphoid). One specific type of leukemia is called eosinophilic leukemia. This is when too many white blood cells called ...

Eosinophilic esophagitis is a condition in which certain white blood cells, called eosinophils, are found in the esophagus. It results in pain, difficulty swallowing, and heartburn. Eosinophilic ...

New findings from the MATINEE and COPD-HELP studies suggest mepolizumab could reduce exacerbations and improve quality of life in patients with eosinophilic chronic obstructive pulmonary disease (COPD ...

we evaluated the efficacy and safety of depemokimab in patients with severe asthma and an eosinophilic phenotype characterized by a high eosinophil count (≥300 cells per microliter in the ...